 Paul MacLean
Concepts (502)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 47 | 2021 | 2565 | 6.130 |
Why?
| | Weight Gain | 23 | 2019 | 497 | 5.850 |
Why?
| | Weight Loss | 20 | 2021 | 740 | 4.790 |
Why?
| | Energy Metabolism | 29 | 2020 | 905 | 4.750 |
Why?
| | Physical Conditioning, Animal | 9 | 2020 | 235 | 3.190 |
Why?
| | Energy Intake | 16 | 2020 | 488 | 2.710 |
Why?
| | Dietary Fats | 14 | 2019 | 363 | 2.320 |
Why?
| | Rats, Wistar | 17 | 2021 | 444 | 1.800 |
Why?
| | Caloric Restriction | 5 | 2019 | 121 | 1.780 |
Why?
| | Body Weight | 15 | 2020 | 1049 | 1.750 |
Why?
| | Diet, High-Fat | 14 | 2021 | 225 | 1.740 |
Why?
| | Lactation | 7 | 2019 | 211 | 1.730 |
Why?
| | Adipose Tissue | 13 | 2018 | 625 | 1.710 |
Why?
| | Milk, Human | 4 | 2018 | 109 | 1.580 |
Why?
| | Appetite | 2 | 2020 | 82 | 1.540 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 85 | 1.410 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 44 | 1.410 |
Why?
| | Body Composition | 10 | 2021 | 709 | 1.350 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 123 | 1.310 |
Why?
| | Lipid Metabolism | 9 | 2017 | 503 | 1.260 |
Why?
| | Adipocytes | 5 | 2017 | 189 | 1.210 |
Why?
| | Motor Activity | 3 | 2019 | 790 | 1.200 |
Why?
| | Ovary | 3 | 2017 | 198 | 1.180 |
Why?
| | Ovariectomy | 8 | 2019 | 110 | 1.180 |
Why?
| | Appetite Regulation | 2 | 2017 | 43 | 1.170 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 516 | 1.120 |
Why?
| | Cholesterol | 5 | 2019 | 376 | 1.080 |
Why?
| | Muscle, Skeletal | 18 | 2019 | 1333 | 1.070 |
Why?
| | Animals | 64 | 2021 | 34264 | 1.060 |
Why?
| | Rats | 29 | 2021 | 6717 | 1.060 |
Why?
| | Estrogens | 3 | 2018 | 310 | 1.030 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 21 | 1.020 |
Why?
| | Lipogenesis | 3 | 2019 | 77 | 1.000 |
Why?
| | Vasopressins | 3 | 2021 | 139 | 0.980 |
Why?
| | Eating | 4 | 2020 | 313 | 0.980 |
Why?
| | Receptor, Insulin | 3 | 2015 | 106 | 0.930 |
Why?
| | Glycoproteins | 5 | 2005 | 342 | 0.930 |
Why?
| | Exercise | 10 | 2019 | 1531 | 0.920 |
Why?
| | Liver | 10 | 2021 | 1802 | 0.910 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 388 | 0.910 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 206 | 0.900 |
Why?
| | Cold Temperature | 2 | 2019 | 152 | 0.870 |
Why?
| | Oxygen Consumption | 5 | 2019 | 678 | 0.870 |
Why?
| | Breast Feeding | 4 | 2018 | 314 | 0.860 |
Why?
| | Thermogenesis | 2 | 2019 | 47 | 0.860 |
Why?
| | Insulin | 18 | 2019 | 1972 | 0.850 |
Why?
| | Milk | 5 | 2019 | 137 | 0.840 |
Why?
| | Sex Characteristics | 3 | 2021 | 629 | 0.810 |
Why?
| | Physical Exertion | 3 | 2011 | 273 | 0.810 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 86 | 0.810 |
Why?
| | Menopause | 2 | 2019 | 250 | 0.780 |
Why?
| | Carrier Proteins | 6 | 2005 | 810 | 0.780 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 57 | 0.760 |
Why?
| | Mammary Neoplasms, Experimental | 2 | 2017 | 74 | 0.730 |
Why?
| | Cortical Bone | 1 | 2017 | 12 | 0.730 |
Why?
| | Adipogenesis | 1 | 2017 | 47 | 0.730 |
Why?
| | Adiposity | 5 | 2016 | 431 | 0.730 |
Why?
| | Metformin | 2 | 2018 | 251 | 0.730 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 38 | 0.710 |
Why?
| | Ibuprofen | 1 | 2017 | 74 | 0.700 |
Why?
| | Breast Neoplasms | 5 | 2018 | 1886 | 0.680 |
Why?
| | Bone Density | 1 | 2019 | 367 | 0.670 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 91 | 0.670 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 38 | 0.660 |
Why?
| | Mothers | 4 | 2018 | 534 | 0.660 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 378 | 0.650 |
Why?
| | Osteogenesis | 2 | 2017 | 187 | 0.640 |
Why?
| | Female | 47 | 2021 | 59707 | 0.640 |
Why?
| | Diet, Reducing | 3 | 2016 | 97 | 0.630 |
Why?
| | Oxytocin | 1 | 2015 | 72 | 0.620 |
Why?
| | Therapies, Investigational | 1 | 2014 | 16 | 0.610 |
Why?
| | Overweight | 2 | 2018 | 422 | 0.600 |
Why?
| | Fructose | 5 | 2021 | 179 | 0.590 |
Why?
| | Gene Expression Regulation | 9 | 2021 | 2566 | 0.590 |
Why?
| | Diet | 7 | 2019 | 945 | 0.580 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 331 | 0.570 |
Why?
| | Mice | 28 | 2021 | 14765 | 0.560 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 52 | 0.550 |
Why?
| | Blood Glucose | 10 | 2019 | 1689 | 0.540 |
Why?
| | Fructokinases | 5 | 2021 | 59 | 0.540 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 852 | 0.530 |
Why?
| | Overnutrition | 1 | 2012 | 38 | 0.520 |
Why?
| | Disease Models, Animal | 10 | 2021 | 3738 | 0.520 |
Why?
| | Fatty Liver | 5 | 2018 | 261 | 0.510 |
Why?
| | Transcription Factors | 11 | 2019 | 1593 | 0.500 |
Why?
| | Recurrence | 4 | 2019 | 969 | 0.500 |
Why?
| | Estrous Cycle | 1 | 2010 | 20 | 0.460 |
Why?
| | Leptin | 5 | 2018 | 224 | 0.460 |
Why?
| | Homeostasis | 7 | 2015 | 513 | 0.460 |
Why?
| | Lipoproteins | 3 | 2000 | 170 | 0.460 |
Why?
| | Male | 48 | 2021 | 58392 | 0.450 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 145 | 0.450 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 332 | 0.450 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 107 | 0.440 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 38 | 0.440 |
Why?
| | Vitamin D | 1 | 2013 | 326 | 0.420 |
Why?
| | Humans | 48 | 2021 | 104249 | 0.410 |
Why?
| | Biomedical Research | 2 | 2014 | 574 | 0.410 |
Why?
| | RNA, Messenger | 10 | 2019 | 2914 | 0.410 |
Why?
| | Insulin Resistance | 7 | 2019 | 1076 | 0.410 |
Why?
| | Body Mass Index | 9 | 2018 | 2001 | 0.390 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 170 | 0.390 |
Why?
| | Pregnancy | 6 | 2018 | 4800 | 0.390 |
Why?
| | Intra-Abdominal Fat | 1 | 2008 | 68 | 0.370 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 30 | 0.370 |
Why?
| | Calorimetry, Indirect | 4 | 2018 | 109 | 0.350 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1260 | 0.350 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 205 | 0.350 |
Why?
| | Time Factors | 10 | 2019 | 7066 | 0.350 |
Why?
| | Triglycerides | 8 | 2019 | 540 | 0.340 |
Why?
| | Lymphoma | 1 | 2007 | 180 | 0.340 |
Why?
| | Adenocarcinoma | 1 | 2012 | 745 | 0.340 |
Why?
| | Mice, Knockout | 12 | 2021 | 2809 | 0.340 |
Why?
| | Neurons | 1 | 2015 | 1514 | 0.330 |
Why?
| | Fatty Acids | 6 | 2018 | 374 | 0.330 |
Why?
| | Multiple Myeloma | 1 | 2007 | 115 | 0.330 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2033 | 0.320 |
Why?
| | Epithelium | 2 | 2019 | 281 | 0.320 |
Why?
| | Dehydration | 2 | 2016 | 70 | 0.320 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 149 | 0.320 |
Why?
| | Leukemia | 1 | 2007 | 211 | 0.320 |
Why?
| | Resistance Training | 3 | 2017 | 79 | 0.310 |
Why?
| | Photoperiod | 2 | 2019 | 50 | 0.310 |
Why?
| | Muscle Proteins | 4 | 2012 | 218 | 0.310 |
Why?
| | Mice, Inbred C57BL | 14 | 2021 | 4997 | 0.310 |
Why?
| | Basal Metabolism | 2 | 2018 | 72 | 0.310 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 356 | 0.300 |
Why?
| | Feeding Behavior | 4 | 2018 | 523 | 0.300 |
Why?
| | Hospitalization | 1 | 2013 | 1486 | 0.300 |
Why?
| | Glucose | 7 | 2018 | 819 | 0.290 |
Why?
| | Physical Fitness | 2 | 2016 | 196 | 0.280 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 23 | 0.280 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1409 | 0.280 |
Why?
| | Animals, Newborn | 3 | 2017 | 906 | 0.280 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 324 | 0.270 |
Why?
| | Arteriosclerosis | 1 | 2003 | 115 | 0.270 |
Why?
| | Transcriptional Activation | 2 | 2002 | 381 | 0.270 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1031 | 0.260 |
Why?
| | Exercise Tolerance | 3 | 2016 | 217 | 0.260 |
Why?
| | Adult | 22 | 2021 | 30359 | 0.260 |
Why?
| | Cell Proliferation | 3 | 2017 | 2276 | 0.260 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2018 | 1796 | 0.250 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1141 | 0.240 |
Why?
| | Polyphenols | 1 | 2021 | 12 | 0.240 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 44 | 0.240 |
Why?
| | Malus | 1 | 2021 | 10 | 0.240 |
Why?
| | Disease Progression | 4 | 2018 | 2341 | 0.230 |
Why?
| | Feces | 2 | 2021 | 358 | 0.230 |
Why?
| | Hygromycin B | 1 | 2000 | 2 | 0.230 |
Why?
| | Liver X Receptors | 2 | 2019 | 31 | 0.230 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 34 | 0.230 |
Why?
| | Child Development | 2 | 2018 | 468 | 0.230 |
Why?
| | Cinnamates | 1 | 2000 | 9 | 0.230 |
Why?
| | Adiponectin | 3 | 2018 | 206 | 0.230 |
Why?
| | Animal Feed | 2 | 2019 | 48 | 0.230 |
Why?
| | Hyperinsulinism | 1 | 2001 | 105 | 0.230 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 4 | 0.220 |
Why?
| | Kynurenic Acid | 1 | 2020 | 10 | 0.220 |
Why?
| | Fruit | 1 | 2021 | 110 | 0.220 |
Why?
| | Fasting | 3 | 2016 | 280 | 0.220 |
Why?
| | Random Allocation | 2 | 2019 | 387 | 0.220 |
Why?
| | Starch | 1 | 2019 | 19 | 0.220 |
Why?
| | Nutritive Value | 1 | 2019 | 30 | 0.210 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 105 | 0.210 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 14 | 0.210 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 68 | 0.210 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 29 | 0.210 |
Why?
| | Weaning | 1 | 2019 | 60 | 0.210 |
Why?
| | Metabolic Diseases | 2 | 2018 | 93 | 0.210 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1472 | 0.210 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 284 | 0.200 |
Why?
| | Membrane Proteins | 3 | 2015 | 1049 | 0.200 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 131 | 0.200 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 33 | 0.200 |
Why?
| | Aromatase | 1 | 2018 | 26 | 0.200 |
Why?
| | Tamoxifen | 2 | 2018 | 184 | 0.200 |
Why?
| | Behavior Therapy | 1 | 2021 | 225 | 0.190 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 480 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 214 | 0.190 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 39 | 0.190 |
Why?
| | Postmenopause | 3 | 2018 | 339 | 0.190 |
Why?
| | Perilipin-1 | 1 | 2017 | 20 | 0.190 |
Why?
| | Diglycerides | 1 | 2018 | 50 | 0.190 |
Why?
| | Glycogen | 6 | 2010 | 78 | 0.190 |
Why?
| | Ghrelin | 2 | 2018 | 33 | 0.190 |
Why?
| | Cell Size | 1 | 2017 | 89 | 0.190 |
Why?
| | Middle Aged | 18 | 2021 | 27633 | 0.190 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 40 | 0.190 |
Why?
| | Sphingolipids | 1 | 2018 | 40 | 0.190 |
Why?
| | Glaucoma | 1 | 2020 | 140 | 0.190 |
Why?
| | Analysis of Variance | 4 | 2016 | 1580 | 0.190 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 56 | 0.190 |
Why?
| | Signal Transduction | 4 | 2018 | 4845 | 0.190 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2151 | 0.190 |
Why?
| | Rest | 1 | 2018 | 136 | 0.180 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 13 | 0.180 |
Why?
| | Models, Animal | 1 | 2019 | 392 | 0.180 |
Why?
| | African Continental Ancestry Group | 1 | 2000 | 435 | 0.180 |
Why?
| | Sucrose | 2 | 2018 | 151 | 0.180 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 48 | 0.180 |
Why?
| | Reperfusion Injury | 1 | 2020 | 288 | 0.180 |
Why?
| | Running | 1 | 2019 | 225 | 0.180 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 16 | 0.180 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 3223 | 0.180 |
Why?
| | Chromatography, Gas | 1 | 2016 | 42 | 0.180 |
Why?
| | Hyperuricemia | 1 | 2018 | 126 | 0.180 |
Why?
| | Dyslipidemias | 1 | 2018 | 154 | 0.170 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 192 | 0.170 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 80 | 0.170 |
Why?
| | Thinness | 2 | 2012 | 89 | 0.170 |
Why?
| | Receptors, Androgen | 1 | 2017 | 114 | 0.170 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.170 |
Why?
| | PPAR gamma | 1 | 2017 | 177 | 0.170 |
Why?
| | Cattle | 1 | 2019 | 990 | 0.170 |
Why?
| | Glucokinase | 1 | 2015 | 15 | 0.170 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 64 | 0.170 |
Why?
| | Neural Pathways | 2 | 2011 | 337 | 0.170 |
Why?
| | Fibroblasts | 2 | 2017 | 850 | 0.170 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 17 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 126 | 0.160 |
Why?
| | Obesity, Morbid | 1 | 2000 | 261 | 0.160 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 6 | 0.160 |
Why?
| | Hypothalamus | 1 | 2016 | 201 | 0.160 |
Why?
| | Methylnitrosourea | 2 | 2018 | 8 | 0.160 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 312 | 0.160 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 218 | 0.160 |
Why?
| | Down-Regulation | 3 | 2008 | 684 | 0.150 |
Why?
| | Caffeine | 1 | 1995 | 67 | 0.150 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2014 | 101 | 0.150 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 472 | 0.150 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 37 | 0.150 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 438 | 0.150 |
Why?
| | Research Report | 1 | 2014 | 65 | 0.150 |
Why?
| | Acinar Cells | 1 | 2013 | 10 | 0.140 |
Why?
| | Postpartum Period | 1 | 2016 | 223 | 0.140 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2013 | 23 | 0.140 |
Why?
| | European Continental Ancestry Group | 1 | 2000 | 1337 | 0.140 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1302 | 0.140 |
Why?
| | DNA Methylation | 1 | 2017 | 373 | 0.140 |
Why?
| | Birth Weight | 1 | 2016 | 390 | 0.140 |
Why?
| | Pantothenic Acid | 1 | 2013 | 3 | 0.140 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 22 | 0.140 |
Why?
| | Vitamin A | 1 | 2013 | 43 | 0.140 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 89 | 0.140 |
Why?
| | Circadian Rhythm | 2 | 2009 | 442 | 0.140 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 498 | 0.140 |
Why?
| | Bariatric Surgery | 1 | 2017 | 241 | 0.140 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 138 | 0.130 |
Why?
| | Extracellular Space | 1 | 2013 | 156 | 0.130 |
Why?
| | Integrases | 1 | 2013 | 119 | 0.130 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 9 | 0.130 |
Why?
| | Research Design | 1 | 2018 | 834 | 0.130 |
Why?
| | Cytoskeleton | 1 | 2013 | 167 | 0.130 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1854 | 0.130 |
Why?
| | Hormones | 2 | 2010 | 126 | 0.130 |
Why?
| | Cell Separation | 1 | 2013 | 312 | 0.130 |
Why?
| | Biomarkers | 6 | 2019 | 3163 | 0.130 |
Why?
| | Histones | 1 | 2017 | 536 | 0.120 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 77 | 0.120 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 41 | 0.120 |
Why?
| | Infant, Newborn | 3 | 2018 | 4741 | 0.120 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2013 | 255 | 0.120 |
Why?
| | Glycolysis | 1 | 2012 | 212 | 0.120 |
Why?
| | Colon | 1 | 2013 | 194 | 0.120 |
Why?
| | Morphogenesis | 1 | 2012 | 169 | 0.120 |
Why?
| | Up-Regulation | 2 | 2013 | 970 | 0.120 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 944 | 0.120 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 149 | 0.120 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 76 | 0.120 |
Why?
| | Interleukin-10 | 1 | 2013 | 330 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 175 | 0.120 |
Why?
| | Bone and Bones | 1 | 2012 | 231 | 0.110 |
Why?
| | Lipoprotein Lipase | 2 | 2008 | 78 | 0.110 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 375 | 0.110 |
Why?
| | Metalloproteases | 1 | 2010 | 27 | 0.110 |
Why?
| | Acetaminophen | 1 | 2012 | 199 | 0.110 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 25 | 0.110 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 879 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2015 | 364 | 0.110 |
Why?
| | Patient Compliance | 1 | 2014 | 601 | 0.110 |
Why?
| | Hypertension | 1 | 2018 | 1110 | 0.110 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 212 | 0.110 |
Why?
| | Colorado | 2 | 2019 | 4483 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 354 | 0.110 |
Why?
| | Alkylating Agents | 1 | 2009 | 27 | 0.110 |
Why?
| | Perilipin-2 | 3 | 2015 | 52 | 0.110 |
Why?
| | Fats | 1 | 2009 | 19 | 0.110 |
Why?
| | Mitochondria | 2 | 2018 | 720 | 0.100 |
Why?
| | Infant | 3 | 2018 | 7629 | 0.100 |
Why?
| | Self Report | 1 | 2013 | 603 | 0.100 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 203 | 0.100 |
Why?
| | Species Specificity | 1 | 2011 | 653 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 139 | 0.100 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 235 | 0.100 |
Why?
| | Transcriptome | 1 | 2013 | 489 | 0.100 |
Why?
| | Health Behavior | 1 | 2014 | 673 | 0.100 |
Why?
| | Cross-Over Studies | 2 | 2021 | 465 | 0.100 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 167 | 0.100 |
Why?
| | Interleukin-4 | 1 | 2009 | 237 | 0.100 |
Why?
| | Disease Susceptibility | 3 | 2016 | 299 | 0.100 |
Why?
| | Interleukin-2 | 1 | 2009 | 383 | 0.100 |
Why?
| | Risk Factors | 3 | 2018 | 8467 | 0.100 |
Why?
| | Retrospective Studies | 3 | 2018 | 10064 | 0.100 |
Why?
| | Treatment Outcome | 3 | 2016 | 8608 | 0.100 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 18 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2291 | 0.090 |
Why?
| | Hyperplasia | 1 | 2008 | 175 | 0.090 |
Why?
| | Antigens, CD34 | 1 | 2007 | 94 | 0.090 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 100 | 0.090 |
Why?
| | Phosphorylation | 2 | 2012 | 1765 | 0.090 |
Why?
| | Adolescent | 5 | 2021 | 17541 | 0.090 |
Why?
| | Protein-Serine-Threonine Kinases | 2 | 2001 | 601 | 0.090 |
Why?
| | Patient Selection | 2 | 2009 | 693 | 0.090 |
Why?
| | Leukocyte Count | 1 | 2007 | 316 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2013 | 1008 | 0.090 |
Why?
| | Lactates | 3 | 1995 | 96 | 0.080 |
Why?
| | Exercise Test | 1 | 2009 | 578 | 0.080 |
Why?
| | Calorimetry | 3 | 2012 | 69 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1571 | 0.080 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 59 | 0.080 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 192 | 0.080 |
Why?
| | Gluconeogenesis | 1 | 2006 | 78 | 0.080 |
Why?
| | Young Adult | 5 | 2021 | 10261 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2013 | 1729 | 0.080 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 9 | 0.080 |
Why?
| | Reference Values | 1 | 2007 | 887 | 0.080 |
Why?
| | Cell Line | 3 | 2019 | 2946 | 0.080 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 41 | 0.080 |
Why?
| | Lipolysis | 1 | 2005 | 51 | 0.080 |
Why?
| | Macrophages | 1 | 2012 | 1157 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2019 | 3225 | 0.080 |
Why?
| | Proteins | 2 | 2013 | 950 | 0.070 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 202 | 0.070 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 60 | 0.070 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 57 | 0.070 |
Why?
| | Models, Biological | 2 | 2018 | 1842 | 0.070 |
Why?
| | Aged | 5 | 2018 | 18934 | 0.070 |
Why?
| | Antigens, CD | 1 | 2007 | 562 | 0.070 |
Why?
| | Organ Specificity | 1 | 2005 | 321 | 0.070 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 6 | 0.070 |
Why?
| | Kinetics | 2 | 2012 | 1788 | 0.070 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 231 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 594 | 0.070 |
Why?
| | Food Deprivation | 1 | 2003 | 29 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 378 | 0.070 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 243 | 0.070 |
Why?
| | United States | 2 | 2018 | 11035 | 0.070 |
Why?
| | Protein Kinases | 2 | 2002 | 352 | 0.070 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 38 | 0.060 |
Why?
| | Lactic Acid | 4 | 2002 | 293 | 0.060 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 12 | 0.060 |
Why?
| | Neutrophils | 1 | 2007 | 1156 | 0.060 |
Why?
| | Drinking | 1 | 2021 | 45 | 0.060 |
Why?
| | Hep G2 Cells | 1 | 2021 | 65 | 0.060 |
Why?
| | Diabetes Complications | 1 | 2003 | 243 | 0.060 |
Why?
| | Intestines | 2 | 2015 | 302 | 0.060 |
Why?
| | Blotting, Southern | 1 | 2000 | 83 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 3662 | 0.060 |
Why?
| | Hindlimb | 3 | 1995 | 130 | 0.060 |
Why?
| | Calmodulin | 1 | 2000 | 93 | 0.060 |
Why?
| | Calcineurin | 1 | 2000 | 96 | 0.050 |
Why?
| | Lipoproteins, HDL | 1 | 2000 | 88 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2018 | 6518 | 0.050 |
Why?
| | Rumen | 1 | 2019 | 4 | 0.050 |
Why?
| | Medicago sativa | 1 | 2019 | 2 | 0.050 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 104 | 0.050 |
Why?
| | Dairying | 1 | 2019 | 7 | 0.050 |
Why?
| | Neoplasms | 1 | 2012 | 1913 | 0.050 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 11 | 0.050 |
Why?
| | Benzylamines | 1 | 2019 | 32 | 0.050 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 146 | 0.050 |
Why?
| | New Zealand | 1 | 2019 | 43 | 0.050 |
Why?
| | Genes, Reporter | 1 | 2000 | 304 | 0.050 |
Why?
| | Benzoates | 1 | 2019 | 36 | 0.050 |
Why?
| | Postprandial Period | 1 | 2019 | 118 | 0.050 |
Why?
| | Mathematical Concepts | 1 | 2018 | 22 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2019 | 193 | 0.050 |
Why?
| | Dietary Proteins | 1 | 2019 | 134 | 0.050 |
Why?
| | Japan | 1 | 2018 | 90 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 126 | 0.050 |
Why?
| | Sarcolemma | 1 | 2018 | 29 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2000 | 378 | 0.050 |
Why?
| | Nuclear Transfer Techniques | 1 | 2017 | 4 | 0.050 |
Why?
| | Stromal Cells | 1 | 2018 | 124 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 515 | 0.050 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 37 | 0.050 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 128 | 0.050 |
Why?
| | Nutrition Surveys | 1 | 2018 | 152 | 0.050 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 34 | 0.050 |
Why?
| | Blastocyst | 1 | 2017 | 45 | 0.050 |
Why?
| | Breast | 1 | 2018 | 142 | 0.050 |
Why?
| | Transfection | 1 | 2000 | 1002 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 60 | 0.050 |
Why?
| | Cytokines | 2 | 2018 | 1868 | 0.050 |
Why?
| | Muscle Contraction | 1 | 2000 | 411 | 0.050 |
Why?
| | Cytosol | 1 | 2018 | 243 | 0.040 |
Why?
| | Water Deprivation | 1 | 2016 | 17 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 692 | 0.040 |
Why?
| | Cyclic AMP | 2 | 1995 | 308 | 0.040 |
Why?
| | Methylation | 1 | 2017 | 221 | 0.040 |
Why?
| | Progesterone | 1 | 1998 | 241 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 369 | 0.040 |
Why?
| | Teratoma | 1 | 2017 | 86 | 0.040 |
Why?
| | Steroids | 1 | 2017 | 137 | 0.040 |
Why?
| | Isoenzymes | 2 | 2012 | 379 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 181 | 0.040 |
Why?
| | Epinephrine | 2 | 1994 | 185 | 0.040 |
Why?
| | Phosphocreatine | 1 | 1995 | 40 | 0.040 |
Why?
| | Linear Models | 1 | 2018 | 876 | 0.040 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 41 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 372 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2019 | 1609 | 0.040 |
Why?
| | Child | 1 | 2013 | 15648 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 319 | 0.040 |
Why?
| | Uric Acid | 1 | 2018 | 320 | 0.040 |
Why?
| | Perfusion | 1 | 1995 | 194 | 0.040 |
Why?
| | Fructosediphosphates | 1 | 1994 | 3 | 0.040 |
Why?
| | Testosterone | 1 | 2017 | 280 | 0.040 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 32 | 0.040 |
Why?
| | Lipids | 1 | 1998 | 592 | 0.040 |
Why?
| | Hot Temperature | 1 | 2016 | 373 | 0.040 |
Why?
| | Biopsy | 1 | 2018 | 1058 | 0.040 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.040 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 549 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 915 | 0.040 |
Why?
| | Calcium | 1 | 2000 | 1250 | 0.040 |
Why?
| | Cell Respiration | 1 | 2013 | 78 | 0.040 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 21 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2017 | 674 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4339 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 755 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 64 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 91 | 0.030 |
Why?
| | Muscles | 1 | 1994 | 320 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 439 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 454 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 180 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 163 | 0.030 |
Why?
| | Collagen Type I | 1 | 2012 | 132 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 156 | 0.030 |
Why?
| | Prevalence | 1 | 2018 | 2225 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1913 | 0.030 |
Why?
| | Pilot Projects | 1 | 2016 | 1323 | 0.030 |
Why?
| | Intestine, Small | 1 | 2013 | 172 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 214 | 0.030 |
Why?
| | Blood Pressure | 1 | 2018 | 1654 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2511 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1243 | 0.030 |
Why?
| | Metabolism | 1 | 2010 | 36 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 853 | 0.030 |
Why?
| | Hypoglycemia | 1 | 1994 | 378 | 0.030 |
Why?
| | Proteome | 1 | 2013 | 290 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 2770 | 0.030 |
Why?
| | Glycerol | 1 | 2009 | 85 | 0.030 |
Why?
| | Liver Glycogen | 2 | 2002 | 22 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2013 | 514 | 0.030 |
Why?
| | Phenotype | 2 | 2008 | 2862 | 0.030 |
Why?
| | Risk Assessment | 1 | 2018 | 2934 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1913 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 5605 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 521 | 0.020 |
Why?
| | Birds | 1 | 2008 | 87 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 406 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 283 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 839 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 63 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 27 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 15 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 33 | 0.020 |
Why?
| | Breeding | 1 | 2006 | 69 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 34 | 0.020 |
Why?
| | PPAR alpha | 1 | 2006 | 53 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 37 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 2006 | 114 | 0.020 |
Why?
| | Adenoviridae | 1 | 2006 | 200 | 0.020 |
Why?
| | Brain | 1 | 2018 | 2662 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 2006 | 136 | 0.020 |
Why?
| | Carbon Dioxide | 1 | 2006 | 250 | 0.020 |
Why?
| | Introns | 1 | 2005 | 244 | 0.020 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 10 | 0.020 |
Why?
| | Enzymes | 1 | 2003 | 77 | 0.020 |
Why?
| | Oxazoles | 1 | 2002 | 28 | 0.020 |
Why?
| | Ketones | 1 | 2002 | 43 | 0.020 |
Why?
| | Inflammation | 1 | 2013 | 2171 | 0.020 |
Why?
| | Thiazoles | 1 | 2002 | 126 | 0.020 |
Why?
| | Ribonucleotides | 1 | 2001 | 28 | 0.020 |
Why?
| | Ion Channels | 1 | 2002 | 128 | 0.020 |
Why?
| | Tyrosine | 1 | 2002 | 263 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2001 | 155 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1668 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 975 | 0.010 |
Why?
| | RNA | 1 | 2003 | 757 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 812 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 19 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 361 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 388 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 140 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 430 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3221 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1375 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1998 | 1585 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|